The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Masses

Objectives: Observational data on the impact of on-site cytopathology evaluation (OCE) during endoscopic ultrasonography-guided fine needle aspiration (EUS–FNA) of pancreatic masses have reported conflicting results. We aimed to compare the diagnostic yield of malignancy and proportion of inadequate...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Azar, Riad R. (author)
مؤلفون آخرون: Wani, Sachin (author), Mullady, Daniel (author), Early, Dayna S. (author), Rastogi, Amit (author), Collins, Brian (author), Wang, Jeff F. (author), Marshall, Carrie (author), Sams, Sharon B. (author), Yen, Roy (author)
التنسيق: article
منشور في: 2015
الوصول للمادة أونلاين:http://hdl.handle.net/10725/4438
http://dx.doi.org/10.1038/ajg.2015.262
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://www.nature.com/ajg/journal/v110/n10/full/ajg2015262a.html
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513463596875776
author Azar, Riad R.
author2 Wani, Sachin
Mullady, Daniel
Early, Dayna S.
Rastogi, Amit
Collins, Brian
Wang, Jeff F.
Marshall, Carrie
Sams, Sharon B.
Yen, Roy
author2_role author
author
author
author
author
author
author
author
author
author_facet Azar, Riad R.
Wani, Sachin
Mullady, Daniel
Early, Dayna S.
Rastogi, Amit
Collins, Brian
Wang, Jeff F.
Marshall, Carrie
Sams, Sharon B.
Yen, Roy
author_role author
dc.creator.none.fl_str_mv Azar, Riad R.
Wani, Sachin
Mullady, Daniel
Early, Dayna S.
Rastogi, Amit
Collins, Brian
Wang, Jeff F.
Marshall, Carrie
Sams, Sharon B.
Yen, Roy
dc.date.none.fl_str_mv 2015
2016-09-28T11:28:53Z
2016-09-28T11:28:53Z
2016-09-28
dc.identifier.none.fl_str_mv 0002-9270
http://hdl.handle.net/10725/4438
http://dx.doi.org/10.1038/ajg.2015.262
Wani, S., Mullady, D., Early, D. S., Rastogi, A., Collins, B., Wang, J. F., ... & Romanas, M. (2015). The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Masses: A Prospective Multicenter Randomized Controlled Trial. The American journal of gastroenterology, 110(10), 1429
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://www.nature.com/ajg/journal/v110/n10/full/ajg2015262a.html
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv The American Journal of Gastroenterology
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Masses
A Prospective Multicenter Randomized Controlled Trial
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Objectives: Observational data on the impact of on-site cytopathology evaluation (OCE) during endoscopic ultrasonography-guided fine needle aspiration (EUS–FNA) of pancreatic masses have reported conflicting results. We aimed to compare the diagnostic yield of malignancy and proportion of inadequate specimens between patients undergoing EUS–FNA of pancreatic masses with and without OCE. Methods: In this multicenter randomized controlled trial, consecutive patients with solid pancreatic mass underwent randomization for EUS–FNA with or without OCE. The number of FNA passes in the OCE+ arm was dictated by the on-site cytopathologist, whereas seven passes were performed in OCE− arm. EUS–FNA protocol was standardized, and slides were reviewed by cytopathologists using standardized criteria for cytologic characteristics and diagnosis. Results: A total of 241 patients (121 OCE+, 120 OCE−) were included. There was no difference between the two groups in diagnostic yield of malignancy (OCE+ 75.2% vs. OCE− 71.6%, P=0.45) and proportion of inadequate specimens (9.8 vs. 13.3%, P=0.31). Procedures in OCE+ group required fewer EUS–FNA passes (median, OCE+ 4 vs. OCE− 7, P<0.0001). There was no significant difference between the two groups with regard to overall procedure time, adverse events, number of repeat procedures, costs (based on baseline cost-minimization analysis), and accuracy (using predefined criteria for final diagnosis of malignancy). There was no difference between the two groups with respect to cytologic characteristics of cellularity, bloodiness, number of cells/slide, and contamination. Conclusions: Results of this study demonstrated no significant difference in the diagnostic yield of malignancy, proportion of inadequate specimens, and accuracy in patients with pancreatic mass undergoing EUS–FNA with or without OCE.
eu_rights_str_mv openAccess
format article
id LAURepo_e658ec04755b5d1c728d40b3fcd3ac79
identifier_str_mv 0002-9270
Wani, S., Mullady, D., Early, D. S., Rastogi, A., Collins, B., Wang, J. F., ... & Romanas, M. (2015). The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Masses: A Prospective Multicenter Randomized Controlled Trial. The American journal of gastroenterology, 110(10), 1429
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/4438
publishDate 2015
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic MassesA Prospective Multicenter Randomized Controlled TrialAzar, Riad R.Wani, SachinMullady, DanielEarly, Dayna S.Rastogi, AmitCollins, BrianWang, Jeff F.Marshall, CarrieSams, Sharon B.Yen, RoyObjectives: Observational data on the impact of on-site cytopathology evaluation (OCE) during endoscopic ultrasonography-guided fine needle aspiration (EUS–FNA) of pancreatic masses have reported conflicting results. We aimed to compare the diagnostic yield of malignancy and proportion of inadequate specimens between patients undergoing EUS–FNA of pancreatic masses with and without OCE. Methods: In this multicenter randomized controlled trial, consecutive patients with solid pancreatic mass underwent randomization for EUS–FNA with or without OCE. The number of FNA passes in the OCE+ arm was dictated by the on-site cytopathologist, whereas seven passes were performed in OCE− arm. EUS–FNA protocol was standardized, and slides were reviewed by cytopathologists using standardized criteria for cytologic characteristics and diagnosis. Results: A total of 241 patients (121 OCE+, 120 OCE−) were included. There was no difference between the two groups in diagnostic yield of malignancy (OCE+ 75.2% vs. OCE− 71.6%, P=0.45) and proportion of inadequate specimens (9.8 vs. 13.3%, P=0.31). Procedures in OCE+ group required fewer EUS–FNA passes (median, OCE+ 4 vs. OCE− 7, P<0.0001). There was no significant difference between the two groups with regard to overall procedure time, adverse events, number of repeat procedures, costs (based on baseline cost-minimization analysis), and accuracy (using predefined criteria for final diagnosis of malignancy). There was no difference between the two groups with respect to cytologic characteristics of cellularity, bloodiness, number of cells/slide, and contamination. Conclusions: Results of this study demonstrated no significant difference in the diagnostic yield of malignancy, proportion of inadequate specimens, and accuracy in patients with pancreatic mass undergoing EUS–FNA with or without OCE.PublishedN/A2016-09-28T11:28:53Z2016-09-28T11:28:53Z20152016-09-28Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article0002-9270http://hdl.handle.net/10725/4438http://dx.doi.org/10.1038/ajg.2015.262Wani, S., Mullady, D., Early, D. S., Rastogi, A., Collins, B., Wang, J. F., ... & Romanas, M. (2015). The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Masses: A Prospective Multicenter Randomized Controlled Trial. The American journal of gastroenterology, 110(10), 1429http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttp://www.nature.com/ajg/journal/v110/n10/full/ajg2015262a.htmlenThe American Journal of Gastroenterologyinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/44382021-03-19T10:00:55Z
spellingShingle The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Masses
Azar, Riad R.
status_str publishedVersion
title The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Masses
title_full The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Masses
title_fullStr The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Masses
title_full_unstemmed The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Masses
title_short The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Masses
title_sort The Clinical Impact of Immediate On-Site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Masses
url http://hdl.handle.net/10725/4438
http://dx.doi.org/10.1038/ajg.2015.262
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://www.nature.com/ajg/journal/v110/n10/full/ajg2015262a.html